Ponesimod for the treatment of relapsing multiple sclerosis

Abstract

Ponesimod (Ponvory) is a new sphingosine 1‐phosphate receptor modulator for the treatment of adults with relapsing forms of multiple sclerosis (MS). This article discusses its mode of action, efficacy and adverse effects.